Tvardi Therapeutics’ TTI-109 Phase 1 Study Confirms Prodrug Design, Improved Tolerability and Pharmacodynamic Evidence of STAT3 Target Engagement

TTI-109 delivered TTI-101-equivalent exposure with improved tolerability and meaningful reductions in disease-relevant STAT3-driven immune cell ...

U.S. FDA Grants Priority Review to Agios’ sNDA for Mitapivat in Sickle Cell Disease

FDA’s PDUFA goal date is November 1, 2026If approved, mitapivat is positioned to become the first oral PK activator for patients with sickle cell ...

Agios Pharmaceuticals, Inc.: U.S. FDA Grants Priority Review to Agios' sNDA for Mitapivat in Sickle Cell Disease

FDA's PDUFA goal date is November 1, 2026If approved, mitapivat is positioned to become the first oral PK activator for patients with sickle cell disease CAMBRIDGE, Mass., July 07, 2026 (GLOBE NEWSWIR ...
Morning Overview on MSN

Ozempic helped adults over 65 shed more than 15% of their body weight in a new study

Adults aged 65 and older who took semaglutide 2.4 mg lost an average of 15.4% of their body weight over 68 weeks, according ...

Five-agent AI team could speed clinical trial design using real-world patient records

An artificial intelligence system that operates like a collaborative team of medical experts could accelerate clinical trial ...
Vogue

The 12 Major Interior Design Trends Shaping Our Homes in 2026

Unlike fashion with its endless cycles of newness, interior design tends to run on a slower track. It would be impractical to reinvent your home whenever a new trend surfaced, but surveying the ...
BMJ Open

Mental health outcomes and psychosocial correlates among adult members of business families in Germany (WIFU-GESUND): study protocol for a representative c…

Introduction Mental health is an urgent public health issue with social and economic relevance. Business families play a key ...